Factors Influencing COVID-19 Prevention Behaviors. 2023

Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
Department of Health and Human Performance, Texas A&M University- Commerce, 2600 S Neal Street, 75428, Commerce, TX, USA. Elizabeth.Wachira@tamuc.edu.

COVID-19 remains a public health emergency with prevention guidelines and mitigation strategies being constantly updated to curb the rapid spread of the disease. Despite proven successes of recommended preventive behaviors, there is low uptake of wearing a mask, washing of hands, and social distancing in the United States (US). The purpose of this study was to examine factors that influence COVID-19 preventive behaviors. We used data from the nationally representative COVID-19 Household Impact Survey (n = 19,815) conducted in the US from April to June 2020. Chi-square (χ2) test and bivariate analyses were performed to compare study participants who used all COVID-19 related preventive behaviors and those who did not, and multivariate logistic regressions to determine associations across demographic and social characteristics. Of the 19,815 participants, 79.2% of participants reported practicing the aforementioned COVID-19 preventive behaviors. Further, non-Hispanic white, Spanish speaking, living in urban areas, of older age (60+), being female, having an education above an undergraduate, those with income levels $100K or more, living in the urban northeast region that trust and communicate frequently with family and neighbors were more likely to use all three preventive behaviors. Findings suggest a need for continued provision of information on prevention and vaccination importance, but expand efforts to target adopters of these behaviors and encourage them to share their uptake and adherence efforts. This type of horizontal communication where information is shared within trusted social networks can shape social norms that influence the uptake of COVID-19 preventive behaviors and slowly curb communal spread.

UI MeSH Term Description Entries
D008297 Male Males
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085762 Physical Distancing Maintaining recommended amount of spatial separation between self and others. Physical Distance,Social Distancing,Distance, Physical,Distancing, Physical,Distancing, Social
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
November 2022, Public health,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
August 2020, International journal of environmental research and public health,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
April 2024, Journal of American college health : J of ACH,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
January 2021, BMC public health,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
January 2022, Frontiers in public health,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
December 2022, Journal of Korean Academy of Nursing,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
January 2022, PloS one,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
January 2022, Risk analysis : an official publication of the Society for Risk Analysis,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
April 2022, Annual review of public health,
Elizabeth Wachira, and Kujang Laki, and Bhakti Chavan, and Gloria Aidoo-Frimpong, and Caroline Kingori
May 2024, Asian Pacific journal of allergy and immunology,
Copied contents to your clipboard!